PD-L1 Status in Tenosynovial Giant Cell Tumors
Conclusions: Taking into consideration the high positivity rate of PD-L1 staining in TSGCTs, PD-L1 blockage may be used as a valuable medical treatment for TSGCTs; however, further studies are needed.PMID:36143947 | PMC:PMC9501118 | DOI:10.3390/medicina58091270
Source: Medicina (Kaunas) - Category: Universities & Medical Training Authors: Tulay Zenginkinet Abdullahi Umar Faruq Ayse Nur Toksoz Yildirim Yusuf Iyetin Burak Ozturan Erhan Okay Aykut Celik Korhan Ozkan Muhlik Akyurek Source Type: research
More News: Brain | Cancer | Cancer & Oncology | International Medicine & Public Health | Neurology | Neurosurgery | Pathology | Study | Universities & Medical Training | WHO | Women